Yujing Huang (黄玉晶) , Hao Zhang (张灏) , Buqing Ma (马步青) , Zhe Yu (俞哲) , Shenyi Dai (戴珅懿) , Lu Cheng (程璐) , Li Su (苏里) , Alzheimer’s Disease Neuroimaging Initiative (ADNI), Gaoyi Yang (杨高怡) , Qingguo Ma (马庆国)
{"title":"Converse or reverse? Machine-learning modeling for disease progression: A study based on Alzheimer’s disease continuum cohort","authors":"Yujing Huang (黄玉晶) , Hao Zhang (张灏) , Buqing Ma (马步青) , Zhe Yu (俞哲) , Shenyi Dai (戴珅懿) , Lu Cheng (程璐) , Li Su (苏里) , Alzheimer’s Disease Neuroimaging Initiative (ADNI), Gaoyi Yang (杨高怡) , Qingguo Ma (马庆国)","doi":"10.1016/j.neuroimage.2026.121754","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Longitudinal trajectories from healthy aging to Mild Cognitive Impairment and Alzheimer’s Disease involve complex mechanisms.</div></div><div><h3>Methods</h3><div>We evaluated five machine learning approaches (Random Forest, Support Vector Machines, Radial Basis Function Networks, Backpropagation Networks, Convolutional Neural Network) to assess the importance of potential predictive markers across the health-to-dementia continuum. Using the ADNI cohort across four phases (ADNI1, ADNIGO, ADNI2, ADNI3), we analyzed participants with distinct trajectories: stable, convertible, and reverse progression.</div></div><div><h3>Results</h3><div>Random Forest outperformed other models across key effectiveness metrics and achieved a macro-averaged sensitivity of 70.8 % and specificity of 96.8 % across all participant groups. Random Forest identified visuospatial and memory-related cognitive dysfunction as key predictive clinical features and several amyloid-related neuroimaging biomarkers — including temporal variations of amyloid uptake within inferior lateral ventricles, para-hippocampus—for classifying participant groups. Additionally, plasma APOE4 and long neurofilament light chain levels emerged as promising predictors for tracking progression.</div></div><div><h3>Conclusion</h3><div>These findings highlight the potential of machine learning in classifying disease trajectories.</div></div>","PeriodicalId":19299,"journal":{"name":"NeuroImage","volume":"327 ","pages":"Article 121754"},"PeriodicalIF":5.3000,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroImage","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1053811926000728","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Longitudinal trajectories from healthy aging to Mild Cognitive Impairment and Alzheimer’s Disease involve complex mechanisms.
Methods
We evaluated five machine learning approaches (Random Forest, Support Vector Machines, Radial Basis Function Networks, Backpropagation Networks, Convolutional Neural Network) to assess the importance of potential predictive markers across the health-to-dementia continuum. Using the ADNI cohort across four phases (ADNI1, ADNIGO, ADNI2, ADNI3), we analyzed participants with distinct trajectories: stable, convertible, and reverse progression.
Results
Random Forest outperformed other models across key effectiveness metrics and achieved a macro-averaged sensitivity of 70.8 % and specificity of 96.8 % across all participant groups. Random Forest identified visuospatial and memory-related cognitive dysfunction as key predictive clinical features and several amyloid-related neuroimaging biomarkers — including temporal variations of amyloid uptake within inferior lateral ventricles, para-hippocampus—for classifying participant groups. Additionally, plasma APOE4 and long neurofilament light chain levels emerged as promising predictors for tracking progression.
Conclusion
These findings highlight the potential of machine learning in classifying disease trajectories.
期刊介绍:
NeuroImage, a Journal of Brain Function provides a vehicle for communicating important advances in acquiring, analyzing, and modelling neuroimaging data and in applying these techniques to the study of structure-function and brain-behavior relationships. Though the emphasis is on the macroscopic level of human brain organization, meso-and microscopic neuroimaging across all species will be considered if informative for understanding the aforementioned relationships.